IDEXX Laboratories, Inc. (LON:0J8P)
London · Delayed Price · Currency is GBP · Price in USD | Market Cap | 44.00B |
| Revenue (ttm) | 3.10B |
| Net Income (ttm) | 764.34M |
| Shares Out | n/a |
| EPS (ttm) | 9.37 |
| PE Ratio | 57.56 |
| Forward PE | 52.14 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 3,831 |
| Average Volume | 220 |
| Open | 638.00 |
| Previous Close | 634.14 |
| Day's Range | 638.00 - 734.98 |
| 52-Week Range | 351.94 - 734.98 |
| Beta | 1.58 |
| RSI | 73.66 |
| Earnings Date | Nov 3, 2025 |
About IDEXX Laboratories
IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It offers in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology, and coagulation analyzers; and SNAP rapid assays test kits. The company also provides commercial reference... [Read more]
Financial Performance
In 2024, IDEXX Laboratories's revenue was $3.90 billion, an increase of 6.46% compared to the previous year's $3.66 billion. Earnings were $887.87 million, an increase of 5.07%.
Financial numbers in USD Financial StatementsNews
IDEXX Laboratories (IDXX) Upgraded to Buy with Price Target of $700
IDEXX Laboratories (IDXX) Upgraded to Buy with Price Target of $700
Pre-Market Earnings Report for November 3, 2025 : IDXX, PEG, RYAAY, ARES, BNTX, ON, CNA, PNW, CIFR, AMG, AXSM, BRKR
The following companies are expected to report earnings prior to market open on 11/03/2025. Visit our Earnings Calendar for a full list of expected earnings releases.IDEXX Laboratories, Inc. (IDXX)is ...
If You Invested $100 In IDEXX Laboratories Stock 10 Years Ago, You Would Have This Much Today
IDEXX Laboratories (NASDAQ: IDXX) has outperformed the market over the past 10 years by 12.0% on an annualized basis producing an average annual return of 24.51%. Currently, IDEXX Laboratories has a ...
IDXX: Stifel Upgrades IDEXX Laboratories with New Price Target | IDXX Stock News
IDXX: Stifel Upgrades IDEXX Laboratories with New Price Target | IDXX Stock News
This Hershey Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Friday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings pag...
Idexx Laboratories (IDXX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Idexx (IDXX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
HOLX or IDXX: Which Is the Better Value Stock Right Now?
HOLX vs. IDXX: Which Stock Is the Better Value Option?
Here's How IDEXX Laboratories is Placed Ahead of Q3 Earnings
IDXX heads into Q3 earnings with steady estimates and strong momentum across its diagnostics and pet healthcare segments.
Seilern Investment Management Sells $43 Million Worth of IDEXX Laboratories (NASDAQ: IDXX) Stock
IDEXX Laboratories to Release 2025 Third Quarter Financial Results
WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2025 third quarter financial results for Mond...
Here's How Much You Would Have Made Owning IDEXX Laboratories Stock In The Last 15 Years
IDEXX Laboratories (NASDAQ: IDXX) has outperformed the market over the past 15 years by 9.91% on an annualized basis producing an average annual return of 22.18%. Currently, IDEXX Laboratories has a ...
IDEXX Laboratories (IDXX) Appoints Karen Peacock as New Independent Director
IDEXX Laboratories (IDXX) Appoints Karen Peacock as New Independent Director
IDEXX Laboratories Elects Karen Peacock to Board of Directors
WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced the election of Karen Peacock to the Company's Board of Direct...
IDEXX Laboratories: Recurring Revenue And Market Moat - Why I Choose To Buy
IDXX: UBS Initiates Coverage with Neutral Rating and $720 Price Target | IDXX Stock News
IDXX: UBS Initiates Coverage with Neutral Rating and $720 Price Target | IDXX Stock News
Here's How Much $100 Invested In IDEXX Laboratories 20 Years Ago Would Be Worth Today
IDEXX Laboratories (NASDAQ: IDXX) has outperformed the market over the past 20 years by 3.35% on an annualized basis producing an average annual return of 12.2%. Currently, IDEXX Laboratories has a m...
IDXX Quantitative Stock Analysis
Below is Validea's guru fundamental report for IDEXX LABORATORIES INC (IDXX). Of the 22 guru strategies we follow, IDXX rates highest using our P/B Growth Investor model based on the published strateg...
IDEXX Laboratories, Inc. (IDXX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
IDEXX Laboratories Inc (IDXX) to Participate in Morgan Stanley Global Healthcare Conference | ...
IDEXX Laboratories Inc (IDXX) to Participate in Morgan Stanley Global Healthcare Conference | IDXX stock news
IDEXX Laboratories to Participate in Morgan Stanley 23rd Annual Global Healthcare Conference
WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced that Jay Mazelsky, President and Chief Executive Officer, and ...
Options Exercise: M. Anne Szostak At IDEXX Laboratories Realizes $951K
Highlighted on August 26, it was unveiled in an SEC filing that Szostak, Board Member at IDEXX Laboratories (NASDAQ: IDXX), executed a significant transaction involving the exercise of company stock ...
Insider Selling: Michael G Erickson Unloads $263K Of IDEXX Laboratories Stock
Making a noteworthy insider sell on August 14, Michael G Erickson , Executive Vice President at IDEXX Laboratories (NASDAQ: IDXX), is reported in the latest SEC filing. What Happened: Erickson's deci...
$1000 Invested In IDEXX Laboratories 15 Years Ago Would Be Worth This Much Today
IDEXX Laboratories (NASDAQ: IDXX) has outperformed the market over the past 15 years by 10.61% on an annualized basis producing an average annual return of 23.26%. Currently, IDEXX Laboratories has a...
A Closer Look at IDEXX Laboratories's Options Market Dynamics
Whales with a lot of money to spend have taken a noticeably bearish stance on IDEXX Laboratories . Looking at options history for IDEXX Laboratories (NASDAQ: IDXX) we detected 8 trades. If we conside...
Baron Health Care Fund Q2: Top Contributors, Misses, And Strategic Shifts
Insmed, Intuitive Surgical, and IDEXX Laboratories were top contributors, driven by strong drug pipelines, innovation, and robust financial results. We exited UnitedHealth Group due to earnings misses...